Leading science, pioneering therapies
CRM Publications

Class 3 semaphorins influence oligodendrocyte precursor recruitment and remyelination in adult central nervous system.

TitleClass 3 semaphorins influence oligodendrocyte precursor recruitment and remyelination in adult central nervous system.
Publication TypeJournal Article
Year of Publication2011
Authorsle Piaton G, Aigrot M-S, Williams AC, Moyon S, Tepavcevic V, Moutkine I, Gras J, Matho KS, Schmitt A, Soellner H, Huber AB, Ravassard P, Lubetzki C
JournalBrain
Volume134
IssuePt 4
Pagination1156-67
Date Published2011 Apr
ISSN1460-2156
KeywordsAnimals, Cell Count, Cell Differentiation, Cell Movement, Cells, Cultured, HEK293 Cells, Humans, Immunohistochemistry, Mice, Myelin Basic Protein, Myelin Sheath, Oligodendroglia, Semaphorins, Spinal Cord, Statistics, Nonparametric
Abstract

Oligodendrocyte precursor cells, which persist in the adult central nervous system, are the main source of central nervous system remyelinating cells. In multiple sclerosis, some demyelinated plaques exhibit an oligodendroglial depopulation, raising the hypothesis of impaired oligodendrocyte precursor cell recruitment. Developmental studies identified semaphorins 3A and 3F as repulsive and attractive guidance cues for oligodendrocyte precursor cells, respectively. We previously reported their increased expression in experimental demyelination and in multiple sclerosis. Here, we show that adult oligodendrocyte precursor cells, like their embryonic counterparts, express class 3 semaphorin receptors, neuropilins and plexins and that neuropilin expression increases after demyelination. Using gain and loss of function experiments in an adult murine demyelination model, we demonstrate that semaphorin 3A impairs oligodendrocyte precursor cell recruitment to the demyelinated area. In contrast, semaphorin 3F overexpression accelerates not only oligodendrocyte precursor cell recruitment, but also remyelination rate. These data open new avenues to understand remyelination failure and promote repair in multiple sclerosis.

DOI10.1093/brain/awr022
Alternate JournalBrain
PubMed ID21421691